Abstract
An association between an environmental agent and the development of a malignant tumour was first made by Percival Pott in 1775 when he described the scrotal cancer of chimney sweeps. There have been many reports since then of increased risks of developing certain cancers as a result of exposure to various environmental factors. Rehn, in 1895, was the first to report a cluster of cases of bladder cancer occurring in a chemical dye factory. This was later followed by many similar reports from different countries. Rehn was a practising clinician, and many of the later reports that have led to the identification of urothelial carcinogens have been made by clinicians who have observed unusual clusters of cases and investigated why they have occurred.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abeshouse BA (1943) Exstrophy of the bladder complicated by adenocarcinoma of the bladder and renal calculi. A report of a case and a review of the literature. J Urol 49: 259–289
Altamura MJ, Gonick P, Brooks JJ (1982) Adenocarcinoma of the bladder associated with epispadias: case report and update. J Urol 127: 322–324
Anthony HM, Thomas GM (1970) Bladder tumours and smoking. Int J Cancer 5: 266–272
Arai M, St John M, Fukushima S, Friedell GH, Cohen SM (1983) Long term dose response study of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced urinary bladder carcinogenesis. Cancer Lett 18: 261–269
Armstrong B, Doll R (1974) Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharine consumption. Br J Prev Soc Med 28: 233–240
Arnold DL, Moodie CA, Grice HC, Charbonneau SM, Stavric B, Collins BT, McGuire PF, Zadwidzka ZZ, Munro IC (1980) Long-term toxicity of ortho-toluenesulfonamide and sodium saccharine in the rat. Toxicol Appl Pharmacol 52: 113–152
Berenblum I (1941) The mechanism of carcinogenesis. A study of the significance of cocarcinogenic action and related phenomena. Cancer Res 1: 807–814
Boutwell RK (1964) Some biological aspects of skin carcinogenesis. Progr Exp Tumor Res 4:207–250
Boyland E, Williams DC (1956) The metabolism of tryptophan. Biochem J 64: 578–582
Boyland E, Kinder CH, Manson D (1960) Effect of 1,4-saccharinolactone on induction of bladder cancer. Annu Rep Br Emp Cancer Campaign 38: 45–49
Boyland E, Wallace DM, Avis PRD, Kinder CH (1964) Attempted prophylaxis of bladder cancer with 1,4-glucosaecharolactone. Br J Urol 36: 563–569
Brown RR, Price JM, Satter EJ, Wear JB (1960) The metabolism of tryptophan in patients with bladder cancer. Acta Un Int Cancer 16: 299–307
Byar D, Blackard C (1977) Comparisons of placebo, pyridoxine and topical thiotepa in preventing recurrence of stage 1 bladder cancer. Urology 10 (6): 556–561
Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, Kahn MA (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet II: 842–846
Case RAM, Pearson JT (1954) Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part II; Further consideration of the role of aniline and of the manufacture of auramine and magenta (fuchsine) as possible causative agents. Br J Ind Med 11: 213–216
Case RAM, Hosker ME, McDonald DB, Pearson JT (1954) Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Br J Ind Med 11: 75–104
Chapman WH, Kirchheim D, McRoberts JW (1973) Effect of the urine and calculus formation on the incidence of bladder tumours in rats implanted with paraffin wax pellets. Cancer Res 33: 1225–1229
Clayson DB (1974) Bladder carcinogenesis in rats and mice: possibility of artifacts. J Natl Cancer Inst 52: 1685–1689
Clayson DB, Cooper EH (1970) Cancer of the urinary tract. Adv Cancer Res 13: 271–381
Cohen SM (1983) Promotion of urinary bladder carcinogenesis. Basic Life Sci 24: 253–272
Cohen SM, Arai A, Jacobs JB, Friedell GH (1979) Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res 39: 1207–1217
Cole P (1971) Coffee-drinking and cancer of the lower urinary tract. Lancet I: 1335–1337
Cole P (1973) A population based study of bladder cancer. In: Doll R, Vodopija I (eds) Host environmental interactions in the aetiology of cancer in man. I ARC Scientific Publication No. 7. International Agency for Research on Cancer, Lyon, pp 83–87
Connecticut Tumour Registry (1963-1973) Cancer in Connecticut. Connecticut State Dept of Health, Hartford, Conn
Cramer JW, Miller JA, Miller EC (1960) N-hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluourine. J Biochem Chem 235: 885–862
Cutler SJ, Young JL (eds) (1975) Third national cancer survey: incidence data. Natl Cancer Inst Monogr 41: 1–454
Devesa SS, Silverman DT (1978) Cancer incidence and mortality trends in United States; 1935–1974. J Natl Cancer Inst 60: 545–571
Dodge OG (1962) Tumours of the bladder in Uganda Africans. Acta Un Int Cancers 18: 548–553
Duesburg PH (1983) Retroviral transforming genes in normal cells? Nature 304: 219–225
Duncan RE, Bennet DW, Evans AT, Aron BS, Schellhas HF (1977) Radiation induced bladder tumours. J Urol 118: 43–45
Dunning WF, Curtis MR, Maun ME (1950) The effect of added dietary tryptophan on the occurrence of 2-acetylaminofluorine induced liver and bladder cancer in rats. Cancer Res 10: 454–459
Ekman B, Strombeck JP (1947) Demonstration of tumorgenic decomposition products of 2,3- azotuolene. Acta Physiol Scand 14: 43–52
Engel RME, Wilkinson HA (1970) Bladder exstrophy. J Urol 104: 699
Erturk E, Cohen SM, Price JM, Bryan GT (1969) Pathogenesis,,histology and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N- [4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res 29: 2219–2228
Fairchild WV, Spence CR, Solomon HD, Gangai MP (1979) The incidence of bladder cancer after cyclophosphamide therapy. J Urol 122: 163–167
Friedlander E, Morrison AS (1981) Urinary tryptophan metabolites and cancer of the bladder in humans. J Natl Cancer Inst 67: 347–351
Gonwa TA, Corbett WT, Schey HM, Buckalew VM (1980) Analgesic associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93: 249–252
Harald B, Hauge M (1963) Heredity of cancer elucidated by a study of unselected twins. JAMA 186: 749–753
Harzmann R, Gericke D, Altenahr E, Bichler K-H (1980) Induction of a transplantable urinary bladder carcinoma in dogs. Invest Urol 18: 24–28
Hawksworth GM, Hill MJ (1971) Bacteria and the N-nitrosation of secondary amines. Br J Cancer 25: 520–526
Hawksworth GM, Hill MJ (1974) The in vivo formation of N-nitrosamines in the rat bladder and their subsequent absorption. Br J Cancer 29: 353–358
Hecht SS, Tso TC, Hoffmann D (1976) Selective reduction of tumorgenicity of tobacco smoke. IV Approaches to the reduction of N-nitrosamines and aromatic amines. Proceedings of Third World Conference on smoking and health. Dept Health Education and Welfare Publ No. (NIH) 76, pp 535–545
Hicks RM (1980) Multistage carcinogenesis in the urinary bladder. Br Med Bull 36: 39–46
Hicks RM (1983) The canopic worm: role of bilharziasis in the aetiology of human bladder cancer. J R Soc Med 76: 16–21
Hicks RM, Walters CL, El Sebai I, El Asser AB, El Merzabani M, Gough TA (1977) Demonstration of nitrosamines in human urine. Preliminary observations on a possible aetiology for bladder cancer in association with chronic urinary tract infection. Proc R Soc Med 70: 413–417
Hicks RM, Chowaniec J, Wakefield JStJ (1978) Experimental induction of bladder tumours by a two- stage system. In: Slaga TJ, Sivak A, Boutwell RK (eds) Carcinogenesis, vol 2, Mechanisms of tumour promotion and carcinogenesis. Raven, New York, pp 475–489
Hirayama T (1979) Diet and cancer. Nutr Cancer 1: 67–81
Hoffmann D, Masuda Y, Wynder EL (1969) Alpha-naphthylamine and beta-naphthylamine in cigarette smoke. Nature 221: 254–256
Holsti LR, Ermala R (1955) Papillary carcinoma of the bladder in mice, obtained after peroral administration of tobacco tar. Cancer 8: 679–682
Hoover R, Cole P (1971) Population trends in cigarette smoking and bladder cancer. Am J Epidemiol 94 (5): 409–418
Howe GR, Burch JD, Miller AB (1977) Artificial sweeteners and human bladder cancer. Lancet II: 578–581
Hueper WC, Wiley FH, Wolfe HD (1938) Experimental production of bladder tumours in dogs by administration of beta-naphthylamine. J Indust Hyg Toxicol 20 (1): 46–84
IARC (1980) Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 22. Some non-nutritive sweetening agents. International Agency for Research on Cancer, Lyon
Ito N, Hiasa Y, Tamai A, Okajima E, Kitamura H (1969) Histogenesis of urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann 60: 401–410
Kadlubar FF, Miller J A, Miller EC (1978) Guanyl O6-arylamination and O6-arylation of DNA by the carcinogen N-hydroxy-l-naphthylamine. Cancer Res 38: 3628–3638
Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP, Rossier AB (1977) Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118: 967–971
Lower GM (1982) Concepts in causality: chemically induced human urinary bladder cancer. Cancer 49: 1056–1066
Melick WF, Escue HM, Naryka JJ, Mezera RA, Wheeler EP (1955) The first reported cases of human bladder tumours due to a new carcinogen—xenylamine. J Urol 74: 760–766
Melick WF, Naryka JJ, Kelly RE (1971) Bladder cancer due to exposure to para-aminobiphenyl: a 17 year follow up. J Urol 106: 220–226
Morgan RW, Jain MG (1974) Bladder cancer: smoking, beverages and artificial sweeteners. Can Med Assoc J 111: 1067–1070
Morrison AS, Cole P (1976) Epidemiology of bladder cancer. Urol Clin North Am 3: 13–29
Morrison AS, Cole P (1982) Urinary tract. In: Schottenfeld D, Fraumeni JF, Saunders WB (eds) Cancer epidemiology and prevention. Saunders, Philadelphia, pp 925–937
Morrison AS, Buring JE, Verhoek WG, Aoki K, Leck I, Ohno Y, Obata K (1982) Coffee drinking and cancer of the lower urinary tract. J Natl Cancer Inst 68: 91–94
Morrison R (1978) Cancer of the urinary bladder. Epidemiology and aetiology. Urol Res 6: 183–184
Murasaki G, Cohen SM (1981) Effect of sodium saccharine on urinary bladder epithelial regenerative hyperplasia following freeze ulceration. Cancer Res 43: 182–187
Ohkawa T, Fujinaga T, Doi J, Ebisuno S, Takamatsu M, Nakamura J, Kido R (1982) Clinical study on occupational uroepithelial cancer in Wakayama City. J Urol 128: 520–523
Olson CA, de Vere White RW (1979) Cancer of the bladder. In: Javadpour N (ed) Principles and management of urologic cancer. Williams & Wilkins, Baltimore, pp 337–376
Oyasu R, Hirao Y, Izumi K (1981) Enhancement by urine of urinary bladder carcinogenesis. Cancer Res 41: 478–481
Pamukcu AM, Erturk E, Yalciner S, Bryan GT (1976) Histogenesis of urinary bladder cancer induced in rats by bracken fern. Invest Urol 14: 213–218
Pamukcu AM, Erturk E, Yalciner S, Milli U, Bryan GT (1978) Carcinogenic and mutagenic activities of milks from cows fed bracken fern (Pteridium aquilinum). Cancer Res 38: 1556–1560
Patrianakos C, Hoffman D (1979) Chemical studies on tobacco smoke. LXIV On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 3: 150–254
Payet M (1962) Mortality and morbidity from bladder cancer in West Africa. Acta Un Int Cancer 18: 641–642
Pearson RM, Soloway MS (1978) Does cyclophosphamide induce bladder cancer? Urology 4: 437–447
Petkovic S, Mutavdzic M, Petronic V, Marcovic V (1971) Tumours of the renal pelvis and ureter: clinical and aetiologic studies. J Urol Nephrol (Paris) 77: 429–434
Pott P (1775) Cancer scroti. In: Chirurgical works. Howes Clark & Collins, London
Price JM, Brown RR, Ellis ME (1965) Quantitative studies on the urinary excretion of tryptophan metabolites by human ingesting a constant diet. J Nutr 60: 323–329
Price JM, Biava CG, Oser BL, Vogin EE, Steinfeld J, Ley HL (1970) Bladder tumours in rats fed cyclohexylamine or high doses of a mixture of cyclamate and saccharine. Science 167: 1131–1132
Radomski JL, Brill E (1970) Bladder cancer induction by aromatic amines: Role of N-hydroxy metabolites. Science 167: 992–993
Radomski JL, Greenwald D, Hearn WL, Block NL, Woods FM (1978) Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer. J Urol 120: 48–50
Rathert P, Melchior H-J, Lutzeyer W (1975) Phenacetin: a carcinogen for the urinary tract? J Urol 113: 653–657
Rauschenbach MO, Jarova EI, Protasova TG (1963) Blastomogenic properties of certain metabolites of tryptophan. Acta Un Int Cancer 19: 660–672
Reddy EP, Reynolds RK, Santos E, Barbacid M (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300: 149–152
Rehn L (1895) Blasengeschwülste bei Fuchsin-Arbeits. Arch Klin Chir 50: 588–600
Rehn L (1904) Weitere Erfahrungen über Blasengeschwülste bei Farbarbeitern. Verh Dtsch Ges Chir 33: 231–240
Rowland RG, Henneberry MO, Oyasu R, Grayhack JT (1980) Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res 40: 4524–4527
Rübben H, Hautmann R, Dahm HH (1983) Bladder tumour induction by cytotoxic agents. Clinical experience and experimental data. World J Urol 1: 94–99
RUTTAC [Registry for urinary tract tumours RWTH Aachen] (1981) Arbeitssitzung und Jahresberich des ‘Register und Verbundstudie fur Harnwegstumoren RWTH Aachen’. In: Verhandlungsbericht der Deutschen Gesellschaft für Urologie. Springer, Berlin Heidelberg New York, vol 33, pp 559–564
Sattler TA, Dimitrov T, Hall PW (1977) Relation between endemic (Balkan) nephropathy and urinary tract tumours. Lancet I: 278–280
Segi M, Kurihara M (1972) Cancer mortality for selected sites in 24 countries. Rep No 6, Nagoya Jpn Cancer Soc
Slaga TJ, Fischer SM, Nelson K, Gleason GL (1980) Studies on the mechanism of skin tumour promotion: evidence for several stages in promotion. Proc Natl Acad Sci USA 77: 3659–3663
Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH (1982) Mechanism of activation of a human oncogene. Nature 300: 143–149
Thiede T, Christensen BC (1969) Bladder tumours induced by chlornaphazine. Acta Med Scand 185: 133–137
Wallace DMA, Smith JHF, Billington S, Stemplewski H, Tipton P, Smith M (1984) The promotion of bladder tumours by endoscopic procedures in an animal model. Br J Urol 56: 658–662
Walzer Y, Matheny RB, Blatnik AF, Soloway MS (1983) Urothelial trauma—a mechanism for tumour promotion? World J Urol 1: 100–102
Weinberg DM, Ross RK, Mack TM, Paganini-Hill A, Henderson BE (1983) Bladder cancer etiology. A different perspective. Cancer 51: 675–680
Weinstein RS, Koo C, Pauli BU, Jacobs JB, Friedell GH (1979) Epithelial injury by cystoscopy fluids. Semin Oncol 6 (2): 257–259
Wynder EL, Goldsmith R (1977) The epidemiology of bladder cancer: a second look. Cancer 40: 1246–1268
Yess N, Price JM, Brown RR, Swann PB, Linkswiler H (1964) Vitamin B6 depletion in man: urinary excretion of tryptophan metabolites. J Nutr 84: 229–238
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rübben, H., Lutzeyer, W., Wallace, D.M.A. (1985). The Epidemiology and Aetiology of Bladder Cancer. In: Zingg, E.J., Wallace, D.M.A. (eds) Bladder Cancer. Clinical Practice in Urology. Springer, London. https://doi.org/10.1007/978-1-4471-1362-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1362-1_1
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1364-5
Online ISBN: 978-1-4471-1362-1
eBook Packages: Springer Book Archive